SavedAdd your journal

Journals / Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi / 2018 / Cilt: 10 - Sayı: 1

Current Treatment in Patients with Colorectal Cancer

Kolorektal Kanserlerde Güncel Tedavi Yaklaşımı

Gülhan Güler AVCI
Özge GÜMÜŞAY
Pages
1–7
Publication Date
2018-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

More data is needed for the delay or timing of the surgeon.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Abstract:The primary treatment of rectal cancer is curative surgical resection, but surgery alone may be sufficient in patients with very early stage.
📊
Key Findings & Data:Neoadjuvant radiotherapy, applied in local advanced rectal cancers, significantly reduces local recurrence.
💡
Conclusion & Impact:More data is needed for the delay or timing of the surgeon.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kolorektal kanser · neoadjuvan radyoterapi · kemoterapi

Abstract

Abstract:The primary treatment of rectal cancer is curative surgical resection, but surgery alone may be sufficient in patients with very early stage. Neoadjuvant radiotherapy, applied in local advanced rectal cancers, significantly reduces local recurrence. With the addition of radiotherapy and chemotherapy, pathological complete response and local control rates are increasing. More data is needed for the delay or timing of the surgeon.

Özet

Rektum kanserinin temel tedavi yöntemi küratif cerrahi rezeksiyon olmakla birlikte, sadece çok erken evredeki hastalarda tek başına cerrahi yeterli olabilmektedir. Lokal ileri evre rektum kanserlerinde uygulanan neoadjuvan radyoterapi lokal yinelemeyi anlamlı olarak azaltmaktadır. Radyoterapiye, kemoterapi eklenmesi ile patolojik tam yanıt ve lokal kontrol oranları artmaktadır. Cerrahinin geciktirilmesi veya zamanlaması konusunda ise daha fazla veriye ihtiyaç bulunmaktadır.

🔖

Cite This Article

AVCI, G. G., GÜMÜŞAY, Ö. (2018). Current Treatment in Patients with Colorectal Cancer. Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi, Cilt: 10 - Sayı: 1, 1–7. https://ajindex.com/articles/831107

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Dahlberg M, Glimelius B, Påhlman L. Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial, AnnSurg. 1999;229(4):493-7
  2. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23(24):5644-50
  3. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638-46
  4. Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, el al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excisionfor rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group studyJ Clin Oncol. 2005;23(25):6199-206
  5. Roh MS, Colangelo L, Wieand S. Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum. In: 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA, J ClinOncol 2004:246
  6. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40
  7. Roh MS, Colangelo LH, O'Connell MJ, Yothers G, Deutsch M, Allegra CJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009;27:5124-30
  8. Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J ClinOncol 2006;24:4620-5
  9. Bosset JF, Collette L, Calais G. EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114-23
  10. Bujko K, Nowacki MP, Nasierowska-Guttmejer A. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomized trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004;72:15-24
  11. Bujko K, Nowacki MP, Kepka L. Polish Colorectal Study Group. Postoperative complications in patients irradiated pre-operativ